Literature DB >> 10841805

Synthesis, in vitro anti-breast cancer activity, and intracellular decomposition of amino acid methyl ester and alkyl amide phosphoramidate monoesters of 3'-azido-3'-deoxythymidine (AZT).

V V Iyer1, G W Griesgraber, M R Radmer, E J McIntee, C R Wagner.   

Abstract

We report the synthesis and anticancer activity of a series of AZT phosphoramidate monoesters containing amino acid methyl ester (3a-11a) and N-alkyl amide (3b-11b, 9c-9f) moieties. The aromatic amino acid methyl esters were found to be more cytotoxic than the aliphatic analogues toward MCF-7 cells (human pleural effusion breast adenocarcinoma cell line). A marked stereochemical preference for the L-amino acid stereochemistry was also observed in MCF-7 cells. There was no consistent enhancement of cytotoxicity of the methyl amides over the corresponding methyl esters. AZT and the two AZT aromatic amino acid methyl ester phosphoramidates 8a and 9a were found to be more cytotoxic toward MCF-7 cells than to CEM cells (human T-cell lymphoblastic leukemia). The selective cytotoxicity toward MCF-7 cells may be associated with greater intracellular levels of phosphoramidate monoester and/or phosphorylated AZT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841805     DOI: 10.1021/jm000110g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

2.  Chemopreventive efficacy of stampidine in a murine breast cancer model.

Authors:  Kazim Sahin; Cemal Orhan; Ibrahim Hanifi Ozercan; Mehmet Tuzcu; Birsen Elibol; Taha Koray Sahin; Ulkan Kilic; Sanjive Qazi; Fatih Mehmet Uckun
Journal:  Expert Opin Ther Targets       Date:  2020-02-05       Impact factor: 6.902

3.  Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate.

Authors:  Heng Song; Rachel Johns; George W Griesgraber; Carston R Wagner; Cheryl L Zimmerman
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

4.  Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats.

Authors:  Heng Song; George W Griesgraber; Carston R Wagner; Cheryl L Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 5.  Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids.

Authors:  Harbinder Singh; Jatinder Vir Singh; Kavita Bhagat; Harmandeep Kaur Gulati; Mohit Sanduja; Nitish Kumar; Nihar Kinarivala; Sahil Sharma
Journal:  Bioorg Med Chem       Date:  2019-06-22       Impact factor: 3.641

6.  New access to H-phosphonates via metal-catalyzed phosphorus-oxygen bond formation.

Authors:  Laëtitia Coudray; Isabelle Abrunhosa-Thomas; Jean-Luc Montchamp
Journal:  Tetrahedron Lett       Date:  2007-09-10       Impact factor: 2.415

7.  One-pot synthesis of nucleoside 5'-triphosphates from nucleoside 5'-H-phosphonates.

Authors:  Qi Sun; Jocelyn P Edathil; Runzhi Wu; Eric D Smidansky; Craig E Cameron; Blake R Peterson
Journal:  Org Lett       Date:  2008-04-08       Impact factor: 6.005

8.  Synthesis, antioxidant and antitumoral activities of 5'-arylchalcogeno-3-aminothymidine (ACAT) derivatives.

Authors:  Raquel Mello da Rosa; Bruna Candia Piccoli; Fernanda D'Avila da Silva; Luciano Dornelles; João B T Rocha; Mariana Souza Sonego; Karine Rech Begnini; Tiago Collares; Fabiana K Seixas; Oscar E D Rodrigues
Journal:  Medchemcomm       Date:  2016-12-22       Impact factor: 3.597

9.  Immobilization of Zidovudine Derivatives on the SBA-15 Mesoporous Silica and Evaluation of Their Cytotoxic Activity.

Authors:  Dawid Lewandowski; Marta Lewandowska; Piotr Ruszkowski; Anita Pińska; Grzegorz Schroeder
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.